A New Method of Odds Ratio and Hazard Analysis of Head and Neck Cancer


  • Manoj B. Agravat University of South Florida – COPH, Biostatistics/Epidemiology, 20108 Bluff Oak Blvd Tampa, Florida 33647, USA




Logit, Odds ratio, Hazard ratio, Non-normal probability, Effect modification, Head neck cancer.


The main topic of this paper is to focus on a new method for calculating odds ratios and hazard ratios through probabilities and effect modification. This probability is derived through an odds ratio proof for the common conditional odds ratio of Cochran Mantel Hansel showing theta equals one. Subsequently, the probability formula is obtained and the hazard ratio expression derived. However, the new relation of this proof is to show that logits equals itself through probability. From this derivation, an expression of risk is obtained which is an odds ratio. Parameters are obtained through a novel method of Survreg and its proportional hazard assumption. The odds ratio obtained is given as per strata as well as hazard ratio method demonstrated which is curvilinear to probability in comparison for the interaction model to represent percent change. The odds ratios from PROC GLIMMIX for interaction model has odds ratio of 1.76 vs 1.73 and 1.83 vs 1.76 for white and black males of a logit expression another expression of a logit. A parametric analysis shows correlation to the odds ratios for strata and probability Pr(z) that can work from a new derivation for an odds ratio with for the exposure shown to have power with the RANTBL function of about 83 % with effect modification included at 100% power. The comparison of effect modification P values to hazard ratio is then made for differences across strata.


Agravat M. Formula’s Calculating Risk Estimates and testing for Effect Modification. Pharmasug 2011 [Internet]. 2011 [cited 1 October 2017];. Available from: http://www.lexjansen. com/pharmasug/2011/SP/PharmaSUG-2011-SP03.pdf [

Agravat M. Effect Modification, confounding, hazard ratio, distribution analysis, and probability of non-normal data for head neck cancer. Global SAS 2012 [Internet]. 2012 [cited 1 October 2017];. Available from: http://support.sas.com/ resources/papers/proceedings12/315-2012.pdf

Agravat M. Method for Calculating Odds Ratios Relative Risks, And Interaction. University of South Florida Research Day 2008 [Internet]. 2008 [cited 1 October 2017];. Available from: http://health.usf.edu/medicine/research/ABSTRACT_ BOOK_.pdf

Hasibe et al. M. Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium. Journal of National Cancer Institute. 2007; 99(10): 777-789. DOI: https://doi.org/10.1038/bdj.2007.638

Agravat M. Odds Ratio and Hazard Analysis of Head Neck Cancer by Hpv Status with New Logits and Probability. [Internet]. 2013 [cited 1 January 2017];. Available from: https://www.worldwidejournals.com/indian-journal-of-applied-research-(IJAR)/file.php?val=November_2013_1493100857 __122.pdf

Agravat M. Causal Inference. Sciencewise [Internet]. 2016 [cited 21 December 2017];. Available from: https://www. researchgate.net/publication/299423211_Causal_Inference

Agresti A. An introduction to Categorical Data Analysis. Wiley and sons; 1996.

Hosmer D, Lemeshow S. Applied Survival Analysis. Somerset: Wiley; 1999.

Sousa D. Case-Control Study of Human Papillomavirus and Oropharyngeal Cancer. The New England Journal of Medicine 2007; 356: 1944. DOI: https://doi.org/10.1056/NEJMoa065497

Smith R. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. International Journal of Cancer [Internet]. 2003 [cited 21 December 2017]; 336–344. Available from: http://onlinelibrary.wiley.com/doi/10.1002/ijc.10960/pdf DOI: https://doi.org/10.1002/ijc.10960

Van Ness P, Alford T, Dubin J. Power Simulation for Categorical Data Using the RANTBL Function. Sugi 30 [Internet]. 2017 [cited 1 October 2017];. Available from: http://www2.sas.com/proceedings/sugi30/207-30.pdf

Rapidis, Sarlis, Lefebre. Docetaxel in the treatment of squamous cell carcinoma of the head and neck. Therapeutics in Clinical Risk Management [Internet]. 2008 [cited 10 October 2017];4(5):865-886. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2621396/ DOI: https://doi.org/10.2147/TCRM.S3133

Pol S, Vermorken j. Cetuximab: its unique place in head and neck cancer treatment. Biologics Targets and Therapy [Internet]. 2013 [cited 10 September 2017]; 7: 77-90. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3665438/ DOI: https://doi.org/10.2147/BTT.S43628

Agravat M. A New Effect Modification P Value Test Demonstrated. SESUG 2009 [Internet]. 2009 [cited 10 October 2017];(Statistics and Data Analysis). Available from: http://analytics.ncsu.edu/sesug/2009/SD018.Agravat.pdf

Kumar, Cotran, Robbins. Basic Pathology. WB Saunders; 1999.




How to Cite

Agravat, M. B. (2018). A New Method of Odds Ratio and Hazard Analysis of Head and Neck Cancer. International Journal of Statistics in Medical Research, 7(2), 45–56. https://doi.org/10.6000/1929-6029.2018.07.02.3



General Articles